This review provides a comprehensive exploration of its botanical characteristics, pharmacokinetics, and safety, alongside a critical evaluation of human clinical studies investigating its therapeutic potential
10.1016/j.jconrel.2022.08.046 38 FangZ.SongM.LaiK.CuiM.YinM.LiuK
Specifically, fenofibrate added to statin therapy may be considered to reduce the risk of retinopathy (IIb B), and, when retinopathy is present, adding fenofibrate to statin therapy is recommended to reduce retinopathy progression, need for ocular surgery, and risk of vision loss (I B) [52]
Slower titrationeven when using the same final dosesignificantly reduces nausea incidence
Your eligibility depends on your specific health circumstances, not a single number
CONTRIBUTOR Chip Wienges and Scott Scheiblin are Brokers with CRC Groups Denver office, where they specialize in Healthcare